J 2003

A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders

ŠVESTKA, Jaromír, Oldřich SYNEK and Alexandra ŽOURKOVÁ

Basic information

Original name

A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders

Name in Czech

Dvojitě slepé srovnání účinku Olanzapinu a Quetiapinu při léčbě akutní schizofrenie nebo schizoafektivní poruchy

Authors

ŠVESTKA, Jaromír (203 Czech Republic, guarantor), Oldřich SYNEK (203 Czech Republic) and Alexandra ŽOURKOVÁ (203 Czech Republic)

Edition

European Neuropsychopharmacology, Amsterodam, Elsevier, 2003, 0924-977X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.842

RIV identification code

RIV/00216224:14110/03:00008914

Organization unit

Faculty of Medicine

UT WoS

000185412300390

Keywords in English

olanzapine; quetiapine; schizophrenia; efficacy; side effects

Tags

International impact, Reviewed
Změněno: 24/6/2009 08:58, prof. MUDr. Alexandra Žourková, CSc.

Abstract

V originále

Olanzapine and quetiapine proved as highly efficient and well tolerated antipsychotics in the double-blind trial.Olanzapine was significantly more effective than quetipaine.The benefit of quetiapine icluded influencing serum prolactin and triglyceride.

In Czech

Byla provedena studie: Dvojitě slepé srovnání účinku Olanzapinu a Quetiapinu při léčbě akutní schizofrenie nebo schizoafektivní poruchy